{"hands_on_practices": [{"introduction": "The tumor suppressor protein p53 is a crucial guardian of the genome, but its cellular levels must be tightly controlled to ensure a proper response to stress without unnecessarily halting cell growth. This practice delves into the kinetics of p53 protein homeostasis, modeling its concentration as a balance between constant synthesis and regulated degradation. By analyzing the effect of a drug that inhibits its degradation, you will quantitatively understand how therapeutic strategies can elevate p53 levels to fight cancer [@problem_id:2577944].", "problem": "A human cell line exhibits a basal tumor protein p53 steady state governed by constitutive translation and Mouse Double Minute 2 homolog (MDM2)-mediated ubiquitin-dependent proteasomal degradation. Assume:\n- p53 synthesis proceeds at a constant zero-order rate $k_s$ with units nanomolar per minute (nM min$^{-1}$).\n- p53 degradation obeys first-order kinetics with rate constant $k_d$ (min$^{-1}$).\n- The cellular volume is constant and Nutlin-3, a small-molecule inhibitor of the MDM2–p53 interaction, increases the p53 half-life from $t_{1/2} = 20$ minutes (untreated) to $t_{1/2} = 120$ minutes (Nutlin-3 treated), without altering $k_s$.\n\nStarting from the mass balance $ \\frac{d[\\text{p53}]}{dt} = k_s - k_d [\\text{p53}] $ and the definition of a half-life for a first-order process, derive the expression for the Nutlin-3 treated steady-state concentration $ [\\text{p53}]_{\\text{ss, new}} $ in closed form in terms of $k_s$ only. Express the final steady-state p53 concentration in nanomolar (nM). Do not include units in your final boxed answer. The final answer must be a single closed-form analytic expression.", "solution": "The problem requires the derivation of the steady-state concentration of the tumor suppressor protein p53, denoted as $[\\text{p53}]$, under treatment with Nutlin-3. The dynamics of the system are described by the provided ordinary differential equation, which represents the mass balance for p53 concentration:\n$$\n\\frac{d[\\text{p53}]}{dt} = k_s - k_d [\\text{p53}]\n$$\nHere, $k_s$ is the zero-order rate constant for p53 synthesis, and $k_d$ is the first-order rate constant for its degradation.\n\nA steady state is achieved when the net rate of change of the concentration is zero. Mathematically, this condition is expressed as:\n$$\n\\frac{d[\\text{p53}]}{dt} = 0\n$$\nApplying this condition to the governing equation allows for the determination of the steady-state concentration, which we will denote as $[\\text{p53}]_{\\text{ss}}$.\n$$\n0 = k_s - k_d [\\text{p53}]_{\\text{ss}}\n$$\nSolving for $[\\text{p53}]_{\\text{ss}}$ yields the general expression for the steady-state concentration:\n$$\n[\\text{p53}]_{\\text{ss}} = \\frac{k_s}{k_d}\n$$\nThe problem provides information about the half-life of p53, $t_{1/2}$, which is related to the first-order degradation rate constant $k_d$. The relationship for any first-order process is derived from its integrated rate law, and is given by:\n$$\nk_d = \\frac{\\ln(2)}{t_{1/2}}\n$$\nThe problem states that upon treatment with Nutlin-3, the half-life of p53 increases to a new value, which we denote as $t_{1/2, \\text{new}}$. The given value is $t_{1/2, \\text{new}} = 120$ minutes. This change in half-life corresponds to a new degradation rate constant, $k_{d, \\text{new}}$. The synthesis rate $k_s$ is stated to be unaffected by the treatment.\n\nWe calculate the new degradation rate constant $k_{d, \\text{new}}$ using the new half-life:\n$$\nk_{d, \\text{new}} = \\frac{\\ln(2)}{t_{1/2, \\text{new}}} = \\frac{\\ln(2)}{120}\n$$\nThe units of $t_{1/2, \\text{new}}$ are minutes, so the units of $k_{d, \\text{new}}$ are $\\text{min}^{-1}$, which is consistent with a first-order rate constant.\n\nNow, we can determine the new steady-state concentration, $[\\text{p53}]_{\\text{ss, new}}$, by substituting $k_{d, \\text{new}}$ into the general expression for steady-state concentration:\n$$\n[\\text{p53}]_{\\text{ss, new}} = \\frac{k_s}{k_{d, \\text{new}}}\n$$\nSubstituting the expression for $k_{d, \\text{new}}$ gives:\n$$\n[\\text{p53}]_{\\text{ss, new}} = \\frac{k_s}{\\frac{\\ln(2)}{120}}\n$$\nSimplifying this expression provides the final result for the new steady-state concentration in terms of the synthesis rate $k_s$:\n$$\n[\\text{p53}]_{\\text{ss, new}} = \\frac{120}{\\ln(2)} k_s\n$$\nThe units of this expression are consistent. Given that $k_s$ has units of $\\text{nM min}^{-1}$ and the numerical coefficient $120/\\ln(2)$ has units of $\\text{min}$, the resulting concentration $[\\text{p53}]_{\\text{ss, new}}$ is correctly expressed in $\\text{nM}$. The information regarding the initial half-life of $20$ minutes is not required for this calculation.", "answer": "$$ \\boxed{\\frac{120 k_s}{\\ln(2)}} $$", "id": "2577944"}, {"introduction": "In diploid organisms, one faulty gene copy can sometimes compromise the function of the healthy copy, a phenomenon known as a dominant-negative effect. This exercise provides a quantitative model for this effect in the context of the p53 tumor suppressor, which must assemble into a four-subunit complex, or tetramer, to function [@problem_id:2577918]. You will use principles of probability to calculate the drastic reduction in functional p53 complexes in a heterozygous cell, illustrating why these mutations are so potent in driving cancer.", "problem": "A tumor suppressor protein p53 functions as a tetramer. Consider a cell that is heterozygous for a dominant-negative p53 R175H missense mutation. Assume the following biochemically grounded scenario:\n\n- Both alleles are transcribed and translated at the same rate, so the synthesis flux of wild-type and mutant monomers is equal, denoted by $r$ (molecules per hour).\n- At steady state, the concentration of a species is given by its synthesis flux divided by its first-order degradation rate constant.\n- The wild-type monomer has a degradation rate constant $k_{\\mathrm{deg},W} = 0.50\\,\\mathrm{h}^{-1}$, while the mutant monomer has $k_{\\mathrm{deg},M} = 0.20\\,\\mathrm{h}^{-1}$ due to stabilization in complex with Heat Shock Protein 90 (HSP90).\n- A fraction $q = 0.30$ of mutant monomers are sequestered by Heat Shock Protein 90 (HSP90) in an assembly-incompetent complex and are thus unavailable for tetramer assembly. The remaining fraction $1 - q$ of mutant monomers is free to assemble.\n- Tetramers assemble by random association from a large, well-mixed pool of wild-type and assembly-competent mutant monomers; each monomeric position in a tetramer is sampled independently with probability proportional to the monomer’s steady-state concentration.\n- For the dominant-negative R175H mutant, any tetramer containing at least one mutant subunit fails to bind DNA in a sequence-specific manner and is considered nonfunctional. Only tetramers composed of four wild-type subunits are functional.\n\nUsing these assumptions, compute the fraction of functional tetramers among all tetramers formed at steady state. Express your final result as a decimal number and round to four significant figures.", "solution": "To find the fraction of functional tetramers, we first determine the relative proportions of wild-type and assembly-competent mutant monomers at steady state. The steady-state concentration of a species is its synthesis flux ($r$) divided by its degradation rate constant ($k_{\\mathrm{deg}}$).\n\nThe concentration of wild-type monomers, $[P_{WT}]$, is $[P_{WT}] = \\frac{r}{k_{\\mathrm{deg},W}}$.\nThe total concentration of mutant monomers, $[P_{M,total}]$, is $[P_{M,total}] = \\frac{r}{k_{\\mathrm{deg},M}}$.\nA fraction $q$ of mutant monomers is sequestered, so the concentration of assembly-competent mutant monomers, $[P_{M,comp}]$, is:\n$$[P_{M,comp}] = (1-q) [P_{M,total}] = (1-q) \\frac{r}{k_{\\mathrm{deg},M}}$$\nThe probability of selecting a wild-type monomer, $p_{WT}$, for any position in the tetramer is the ratio of its concentration to the total concentration of monomers in the assembly pool:\n$$p_{WT} = \\frac{[P_{WT}]}{[P_{WT}] + [P_{M,comp}]} = \\frac{\\frac{r}{k_{\\mathrm{deg},W}}}{\\frac{r}{k_{\\mathrm{deg},W}} + (1-q)\\frac{r}{k_{\\mathrm{deg},M}}} = \\frac{k_{\\mathrm{deg},M}}{k_{\\mathrm{deg},M} + (1-q) k_{\\mathrm{deg},W}}$$\nA tetramer is functional only if all four subunits are wild-type. The fraction of functional tetramers, $F_{func}$, is therefore $(p_{WT})^4$. Substituting the numerical values ($k_{\\mathrm{deg},W} = 0.50$, $k_{\\mathrm{deg},M} = 0.20$, $q = 0.30$):\n$$p_{WT} = \\frac{0.20}{0.20 + (1-0.30) \\times 0.50} = \\frac{0.20}{0.20 + 0.35} = \\frac{0.20}{0.55} = \\frac{4}{11}$$\nFinally, we compute the fraction of functional tetramers:\n$$F_{func} = \\left(\\frac{4}{11}\\right)^4 = \\frac{256}{14641} \\approx 0.017485...$$\nRounding to four significant figures gives $0.01749$.", "answer": "$$\\boxed{0.01749}$$", "id": "2577918"}, {"introduction": "Many critical cell fate decisions are governed by signaling switches that operate like a molecular tug-of-war between activating and inhibiting enzymes. This practice models one of the most important switches in cancer: the PI3K/PTEN pathway, where an oncogenic kinase and a tumor suppressor phosphatase competitively regulate the levels of the signaling lipid PIP3 [@problem_id:2577890]. By applying Michaelis-Menten kinetics, you will determine the steady-state balance of this crucial pathway and gain insight into how its dysregulation can fuel constant pro-survival signaling.", "problem": "A central signaling axis in molecular oncology is the interconversion of phosphatidylinositol $4,5$-bisphosphate (PIP2) and phosphatidylinositol $3,4,5$-trisphosphate (PIP3) at the plasma membrane, catalyzed in opposite directions by phosphatidylinositol $3$-kinase (PI3K) and the tumor suppressor phosphatase and tensin homolog (PTEN), respectively. Aberrant activation of PI3K or loss of PTEN rebalances the PIP2/PIP3 pool and drives oncogenic phosphoinositide $3$-kinase–protein kinase B (AKT) signaling. Consider a membrane patch in which the only interconversions among phosphoinositides are PIP2 $\\rightleftharpoons$ PIP3 mediated by these two enzymes, and assume the following experimentally justified bases:\n- The Michaelis–Menten mechanism $E + S \\rightleftharpoons ES \\rightarrow E + P$ applies independently to each enzyme with respect to its phosphoinositide substrate at steady state, with ATP saturating for PI3K and phosphate release not rate limiting for PTEN. Thus, each one-step conversion rate can be described by $v = V_{\\max}\\,\\dfrac{[S]}{K_{m} + [S]}$ with the appropriate substrate $[S]$.\n- The total phosphoinositide pool is conserved on the time scale of interest, so $[{\\rm PIP2}] + [{\\rm PIP3}] = P_{T}$.\n- There are no other synthesis or degradation pathways, no sequestration, and no compartmental exchange on the time scale considered.\n\nLet $P_{T} = $ $20$ $\\mu{\\rm M}$, PI3K parameters $V_{\\max,{\\rm PI3K}} = $ $0.50$ $\\mu{\\rm M}\\,{\\rm s}^{-1}$ and $K_{m,{\\rm PI3K}} = $ $10$ $\\mu{\\rm M}$ with PIP2 as substrate, and PTEN parameters $V_{\\max,{\\rm PTEN}} = $ $0.80$ $\\mu{\\rm M}\\,{\\rm s}^{-1}$ and $K_{m,{\\rm PTEN}} = $ $2.0$ $\\mu{\\rm M}$ with PIP3 as substrate. At the biochemical steady state in this closed two-species system, the forward flux PIP2 $\\rightarrow$ PIP3 equals the reverse flux PIP3 $\\rightarrow$ PIP2.\n\nUsing only the above bases and constraints, compute the steady-state fraction of PIP3, defined as $f \\equiv \\dfrac{[{\\rm PIP3}]}{P_{T}}$. Express $f$ as a unitless decimal and round your answer to four significant figures.", "solution": "The system reaches a steady state when the rate of PIP3 formation by PI3K ($v_{\\rm fwd}$) equals its rate of consumption by PTEN ($v_{\\rm rev}$). Using the Michaelis-Menten equation for each enzyme and the conservation law $[{\\rm PIP2}] = P_T - [{\\rm PIP3}]$, we can set up the steady-state equality. Let $x = [{\\rm PIP3}]$:\n$$ V_{\\max,{\\rm PI3K}}\\,\\dfrac{P_T - x}{K_{m,{\\rm PI3K}} + (P_T - x)} = V_{\\max,{\\rm PTEN}}\\,\\dfrac{x}{K_{m,{\\rm PTEN}} + x} $$\nSubstituting the given numerical values ($P_{T} = 20$, $V_{\\max,{\\rm PI3K}} = 0.50$, $K_{m,{\\rm PI3K}} = 10$, $V_{\\max,{\\rm PTEN}} = 0.80$, $K_{m,{\\rm PTEN}} = 2.0$) and rearranging the expression yields the following quadratic equation for $x$:\n$$ 0.30x^2 - 15.0x + 20.0 = 0 $$\nThis equation has two roots for $x$: $x_1 \\approx 48.63\\,\\mu{\\rm M}$ and $x_2 \\approx 1.371\\,\\mu{\\rm M}$. Since the concentration of PIP3 cannot exceed the total pool size $P_T = 20\\,\\mu{\\rm M}$, the only physically valid solution is $x \\approx 1.371\\,\\mu{\\rm M}$.\nThe problem asks for the steady-state fraction of PIP3, $f = \\dfrac{[{\\rm PIP3}]}{P_{T}}$.\n$$ f = \\frac{x}{P_T} \\approx \\frac{1.371\\,\\mu{\\rm M}}{20\\,\\mu{\\rm M}} \\approx 0.06855 $$\nTo be precise, using the exact solution from the quadratic formula:\n$$ f = \\frac{1}{20} \\left( \\frac{15.0 - \\sqrt{201}}{0.60} \\right) = \\frac{15.0 - \\sqrt{201}}{12.0} \\approx 0.06854609 $$\nRounding to four significant figures gives $0.06855$.", "answer": "$$\\boxed{0.06855}$$", "id": "2577890"}]}